Federal Register / Vol. 73, No. 4 / Monday, January 7, 2008 / Notices 1225 

ESTIMATED ANNUALIZED BURDEN TABLE—Continued 

Agency Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Total ........................................................................................................ ........................ .......................... ........................ 807 

Dated: December 20, 2007. 

Terry Nicolosi, 

Office of the Secretary, Director, Office of 

Resources Management. 

[FR Doc. E7–25431 Filed 1–4–08; 8:45 am] 

BILLING CODE 4151–AE–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2007N–0487] 

Meeting Being Planned to Obtain 

Public Input for Ensuring the Safety of 

Pet Food 

AGENCY: Food and Drug Administration, 

HHS 

ACTION: Notice of intent to schedule and 

hold public meeting. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing its 

intention to schedule and hold a public 

meeting early in 2008 to obtain input 

from stakeholder groups, including, but 

not limited to, the Association of 

American Feed Control Officials 

(AAFCO), veterinary medical 

associations, animal health 

organizations, and pet food 

manufacturers for the development of 

ingredient, processing, and labeling 

standards to ensure the safety of pet 

food. These standards were mandated 

by the FDA Amendments Act of 2007 

(FDAAA). 

Date, Time, and Location: The date, 

time, and location for the 2008 public 

meeting will be announced in a 

subsequent notice that will be published 

in the Federal Register a later date. 

Addresses: A docket has been opened 

at FDA to receive any comments in 

advance of the public meeting. Submit 

written comments to the Division of 

Dockets Management (HFA–305), Food 

and Drug Administration, 5630 Fishers 

Lane, rm. 1061, Rockville, MD 20852. 

Submit electronic comments to either 

http://www.fda.gov/dockets/ecomments 

or http://www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Walter Osborne, Center for Veterinary 

Medicine (HFV–6), Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 240–276–9024, 

FAX: 240–276–9101, or e-mail: 

walter.osborne@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

FDAAA was signed into law by the 

President on September 27, 2007 (Public 

Law 110–085). Title X of the FDAAA 

includes several provisions pertaining 

to food safety, including the safety of 

pet food. Sec. 1002(a)of the new law 

directs that, within 2 years, FDA is to 

issue new regulations to establish 

ingredient standards and definitions, 

processing standards, and updated 

standards for labeling to include 

nutritional and ingredient information. 

This same provision of the law also 

directs that, in developing these new 

regulations, FDA obtain input from its 

stakeholders, including AAFCO, 

veterinary medical associations, animal 

health organizations, and pet food 

manufacturers. In order to obtain such 

input, FDA intends to hold a public 

meeting to hear directly from interested 

stakeholders. 

II. Public Meeting Details 

Because FDA is mandated by 

Congress to establish the new pet food 

requirements within 2 years of 

enactment of the FDAAA, it is 

imperative that the agency begin the 

rulemaking process as soon as possible. 

To that end, FDA intends to hold a 

public meeting in the greater Rockville, 

MD area sometime within the first 3 

months of 2008. After the meeting, FDA 

will review all of the comments 

submitted to the docket prior to 

initiating the regulation drafting 

process. 

III. Comments 

FDA will publish a subsequent notice 

in the Federal Register announcing the 

details of the 2008 public meeting. 

However, anyone wishing to submit 

general comments about the new law as 

it relates to pet food safety or the 

planned public meeting may do so to 

the Division of Dockets Management 

(see Addresses). Submit a single copy of 

electronic comments or two paper 

copies of any written comments, except 

that individuals may submit one paper 

copy. Comments should be identified 

with the full title and the docket 

number found in brackets in the 

heading of this document. Received 

comments will be available for public 

examination in the Division of Dockets 

Management between 9 a.m. and 4 p.m., 

Monday through Friday. You may also 

view received comments on the FDA’s 

Internet site at: http://www.fda.gov/ 

ohrms/dockets. 

Dated: December 27, 2007. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. E7–25599 Filed 1–4–08; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Advisory Child Health and 

Human Development Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Child Health and Human Development 

Council. 

Date: January 24, 2008. 

Open: 8 a.m. to 12:15 p.m. 


pwalker on PROD1PC71 with NOTICES
1226 Federal Register / Vol. 73, No. 4 / Monday, January 7, 2008 / Notices 

Agenda: (1) A report by the Director, 

NICHD; (2) Obstetric and Pediatric 

Pharmacology Branch Presentation; (3) a 

report of the subcommittee on Planning and 

Policy; and other business of the Council. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C-Wing, 

Conference Room 6, Bethesda, MD 20892. 

Closed: 1:30 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C-Wing, 

Conference Room 6, Bethesda, MD 20892. 

Contact Person: Yvonne T. Maddox, PhD, 

Deputy Director, National Institute of Child 

Health and Human Development, NIH, 9000 

Rockville Pike MSC 7510, Building 31, Room 

2A03, Bethesda, MD 20892, (301) 496–1848. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: 

www.nichd.nih.gov/about/nachhd.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program. National 

Institutes of Health, HHS) 

Dated: December 27, 2007. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–6292 Filed 01–04–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Workshops 

Notice is hereby given of a series of 

four scientific workshops organized by 

the Interagency Autism Coordinating 

Committee (IACC). 

The workshops will be closed to the 

public with attendance limited to 

invited participants. The purpose of the 

scientific workshops is to generate 

research priorities that will be used to 

develop the IACC strategic plan for 

Autism Spectrum Disorder (ASD) 

research. The next meeting of the IACC 

when research priorities will be 

discussed is March 14, 2008. 

Name of Committee: Interagency Autism 

Coordinating Committee (IACC). 

Type of meeting: Scientific workshops. 

Date: January 15–18, 2008. 

Time: 9 a.m. to 5 p.m. each day. 

Agenda: Review of research 

accomplishments, funding initiatives and 

research resources for ASD by scientists and 

other ASD stakeholders; discussion and 

generation of high priority research areas and 

initiatives for developing the IACC strategic 

plan for ASD research. 

Place: The Westin Arlington Gateway, 801 

North Glebe Road, Arlington, VA 22203, 

703–717–6200. 

Contact Person: Joyce Y. Chung, MD, 

Interagency Autism Coordinating Committee, 

National Institute of Mental Health, NIH, 

6001 Executive Boulevard, NSC, Room 6198, 

Bethesda, MD 20892–9669, 301–443–3621. 

Information about the IACC is available on 

the Web site: http://www.nimh.nih.gov/ 

research-funding/scientific-meetings/ 

recurring-meetings/iacc/index.shtml. 

Dated: December 27, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–6293 Filed 1–4–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse Draft 

Strategic Plan 

AGENCY: National Institute on Drug 

Abuse, NIH, HHS. 

ACTION: Notice. 

SUMMARY: The National Institute on 

Drug Abuse (NIDA) is developing a 

strategic plan for the next 5 years, and 

invites the public to provide comments 

on a draft of this plan. The draft plan 

will be publicly available through the 

NIDA Draft Strategic Plan Web page 

(http://www.drugabuse.gov/ 

StrategicPlan/Index.html) for 30 days 

from the publication of this Notice. The 

public is invited to provide comments 

via the e-mail address or the postal 

address listed on the NIDA Draft 

Strategic Plan Web page. 

Background: NIDA is the lead Federal 

agency for research on drug abuse and 

addiction. For the past three decades, 

NIDA has led the way in supporting 

research to prevent and treat drug abuse 

and addiction and mitigate the impact 

of their consequences—particularly the 

spread of HIV/AIDS and other infectious 

diseases. Given recent revolutionary 

advances in drug abuse research, NIDA 

has recently undergone a strategic 

planning process gathering 

recommendations from the National 

Advisory Council on Drug Abuse and 

from ongoing dialogue with our various 

stakeholder groups to establish 

achievable goals and objectives for the 

future. 

NIDA’s draft Strategic Plan outlines 

four major goal areas—Prevention, 

Treatment, HIV/AIDS, and Cross Cutting 

Priorities—each with Strategic 

Objectives that will guide NIDA’s 

research agenda for the future. The 

public is invited to review this draft 

plan and provide comments. The draft 

plan may be viewed at http:// 

www.drugabuse.gov/StrategicPlan/ 

Index.html, and hard copies are 

available by calling 301–443–1124 or by 

sending a letter requesting a copy (that 

includes your mailing address) to: 

National Institute on Drug Abuse, Attn: 

Draft Strategic Plan, 6001 Executive 

Blvd., Suite 5213, MSC 9561, Bethesda, 

MD 20892–9561. 

Request for Comments: The public is 

invited to provide comments on the 

draft Strategic Plan. Comments may be 

sent to the email address listed on the 

NIDA Strategic Planning Web page at 

http://www.drugabuse.gov/ 

StrategicPlan/Index.html, or to the 

postal address listed above. 

Comments Due Date: Comments 

regarding NIDA’s draft Strategic Plan 

should be submitted via e-mail to 

stratplan@nida.nih.gov no later than 30 

days after the publication of this Notice. 

Comments mailed to the above postal 

address must be postmarked by the 

same date. 

Dated: December 21, 2007. 

Nora D. Volkow, 

Director, National Institute on Drug Abuse, 

National Institutes of Health. 

[FR Doc. E7–25521 Filed 1–4–08; 11:28 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5121–N–35] 

Notice of Proposed Information 

Collection: Comment Request Loan 

Sales Bidder Qualification Statement 

AGENCY: Office of the Assistant 

Secretary for Housing—Federal Housing 

Commissioner, HUD. 

ACTION: Notice. 

SUMMARY: The proposed information 

collection requirement described below 

will be submitted to the Office of 


pwalker on PROD1PC71 with NOTICES